**HFT Inpatient Discharge Summary**

**Patient Information:**  
- **[B-NAME]Emily Thompson[O]**, MRN# [B-ID]229745863[O], is a [B-AGE]52 y.o.[O] female, admitted to the Cardiology service for evaluation and management of chest pain and shortness of breath.  
- Admission Date: [B-DATE]2/14/2023[O]  
- Discharge Date: [B-DATE]2/20/2023[O]  
- Attending Provider: Dr. [B-NAME]Harold Greene[O]  
- Treatment Team: !! FIRST CONTACT !!: Cardiac Unit Nurse Team - PAGER [B-ID]145678[O]

**Hospital Problems Noted - Resolved**  
- POA Active Problems  
  - Hypertension [B-DATE]2/14/2023[O] - Present Yes  
  - Type 2 Diabetes Mellitus [B-DATE]2/14/2023[O] - Present Yes  
  - Congestive Heart Failure [B-DATE]2/14/2023[O] - Present Yes

**Other Problems**  
- None

**Hospital Course: Brief Overview**  
Mr. [B-NAME]Emily Thompson[O] presented to [B-ORGANIZATION]City General Hospital[O] with chest pain characterized as substernal, exertional with shortness of breath. On admission, her EKG showed new T wave inversions in the anterior leads. She was immediately started on dual antiplatelet therapy and a statin. Given her risk factors and initial cardiac biomarkers, which were elevated, she underwent coronary angiography that showed a 70% stenosis in the left anterior descending artery. A drug-eluting stent was successfully placed. Her post-operative course was uncomplicated, and she was started on a beta-blocker and ACE inhibitor for heart failure management.

**Discharge Condition:**  
- Disposition: Stable  
- Home or Self Care with follow-up at [B-ORGANIZATION]City General Cardiac Rehab[O]  
- Next Appointment: [B-DATE]2/28/2023[O], 10:30 AM with Dr. [B-NAME]Harold Greene[O]

**Discharge Medication List**  
- Aspirin 81 mg tablet: 1 tab daily  
- Atorvastatin 20 mg tablet: 1 tab at bedtime  
- Metoprolol 50 mg tablet: 1 tab twice daily  
- Lisinopril 10 mg tablet: 1 tab daily  
- Follow-Up Instructions: Patient instructed to continue medication as prescribed, monitor blood pressure and blood sugar levels daily, and maintain a low-salt, diabetic-friendly diet. Education provided on recognizing signs of heart failure exacerbation.

**Recommendations for Follow-Up:**  
- Cardiology follow-up in 2 weeks or sooner if symptoms recur.  
- Diabetic education follow-up with [B-ORGANIZATION]City General Diabetic Care Center[O] scheduled for [B-DATE]3/5/2023[O].  
- Heart failure education session recommended within one month.

**Last Recorded Vital Signs:**  
- BP 132/82 mmHg  
- Pulse 78 bpm  
- Temp 36.6 °C (97.9 °F)  
- Resp 16  
- SpO2 97%  

**Pertinent Discharge Physical Exam Findings:**  
- Cardiovascular: Regular rhythm, no murmurs, S1 and S2 noted, no peripheral edema.  
- Respiratory: Clear to auscultation bilaterally.  
- Abdominal: Soft, non-tender, no organomegaly.  
- Extremities: No cyanosis, clubbing, or edema.  
- Neurologic: Alert and oriented × 3, no focal deficits.

**Significant Test or Procedure Results:**  
- Coronary angiography on [B-DATE]2/15/2023[O] indicated 70% LAD stenosis, treated with stenting, showing good flow post-procedure.  
- Echocardiogram showed LVEF of 45%, indicating mild systolic dysfunction.

**Communication:**  
- A follow-up letter and a copy of the discharge summary have been sent to [B-NAME]Dr. Susan Miller[O], the patient’s primary care physician.  

**Education Provided:**  
- Heart disease management, importance of medication adherence, and lifestyle modifications for heart health and diabetes management. 

**Discharge Instructions:**  
- Patient to avoid heavy lifting and strenuous activity for 1 week.  
- Report any symptoms of chest pain, shortness of breath, or leg swelling to the physician immediately.

Signed: [B-NAME]Harold Greene[O], MD, [B-DATE]2/20/2023[O], 11:45 AM  
**[B-ORGANIZATION]City General Hospital[O]**
